Resources

SLIPE 2025-Real World Effectiveness and Immunogenicity of Maternal RSVpreF Vaccination: A Living Systematic Review and Meta-Analysis

Bardach A, Mazzoni A, Klein K, Brizuela M, Nigri C, Ciapponi A, Ballivian J, Sambade JM, Stegelman K, Patel D, Atwell J, Deese J, Fell D, Cox S, Wang L, Xiong X, Stergachis A, Munoz FM, Buekens P, Berrueta M.

ESPID 2026-Real world effectiveness of maternal RSVpref vaccination: A living systematic review and meta-analysis

Castellana N, Mazzoni A, Berrueta M, Bardach A, Ciapponi A, Klein K, Brizuela M, Nigri C, Patel D, Atwell J, Deese J, Cox S, Wang L, Xiong X, Stergachis A, Munoz FM, Buekens P

RSVWW 2026-Real world efficacy/effectiveness and immunogenicity of maternal RSVpref vaccination: A living systematic review and meta-analysis

Berrueta M, Ciapponi A, Mazzoni A, ,Bardach A, Castellana N, Klein K, Brizuela M, Nigri C, Ballivian J, Sambade JM, Stegelmann K, Patel D, Atwell J, Deese J, Cox S, Wang L, Xiong X, Stergachis A, Munoz FM, Buekens P

Covid 19

SADI 2026-Vacunación contra COVID-19 en personas gestantes: ¿sigue protegiendo frente a hospitalización en la era Ómicron?

Stegelmann K , Ballivian J, Bardach A , Brizuela M, Caravario J , Castellana N , Couto E., Mazzoni A , Rodiguez R, Perez Oyola AP, Salva F , Scarafia F, Ciapponi A , Berrueta M ,Buekens P , Munoz FM, Stergachis A, Xiong X ,Sambade J.

Chikungunya

SADI 2026-La fiebre Chikungunya: una amenaza emergente y las vacunas utilizadas en la población pediátrica

Brizuela M, Bardach A ,Caravario J , Castellana N , Couto E., Mazzoni A , Rodiguez R, Perez Oyola AP, Salva F , Sambade J, Scarafia F,Stegelmann K ,Xiong X , Stergachis A, Munoz FM, Buekens P , Ciapponi A , Berrueta M , Ballivian J.

Mpox

SADI 2026-¿Cuánto protege la vacuna MVA-BN contra mpox? Efectividad frente a infección confirmada y desenlaces graves en personas con y sin VIH

Caravario J , Ballivian J, Bardach A , Brizuela M , Castellana N , Mazzoni A , Rodiguez R, Perez Oyola AP, Salva F , Sambade J, Scarafia F,Stegelmann K, Ciapponi A , Berrueta M ,Xiong X , Buekens P ,Munoz FM, Stergachis A , Couto E.

Chikungunya

SADI 2026-Evaluacion de la evidencia sobre vacunas contra Chikungunya ante el aumento regional de casos

Salva F ,Ballivian J, Bardach A , Caravario J , Castellana N , Comande D , Couto E , Mazzoni A , Rodiguez R,Perez Oyola AP, Sambade J, Scarafia F,Stegelmann K, Xiong X , Stergachis A , Munoz FM , Buekens P , Ciapponi A , Berrueta M ,,Brizuela M.

Covid 19

ESPID 2026 – COVID-19 vaccination during pregnancy and infant outcomes: Pandemic and postpandemic evidence from a living systematic review

Munoz FM , Ballivian J, Bardach A , Brizuela M , Caravario J , Castellana N , Comande D , Couto E , Mazzoni A , Salva F , Stegelmann K, Xiong X , Stergachis A , Buekens P , Berrueta M , Ciapponi A , Sambade J.

Mpox

Maternal and Pediatric Use of Vaccines for Mpox: A Living Systematic Review and Meta‑analysis of Safety and Effectiveness

Ciapponi A., Ballivian J.,Berrueta M.,Sambade JM., Castellana N.,Bardach A. , Brizuela ME, Caravario J., Comandé D., Couto E., Mazzoni A., Parker E., Salva F., Stegelmann K., Xiong X .,Stergachis A., Munoz F., Buekens P.

Lassa Fever

Efficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates

Ariel Bardach, Mabel Berrueta, Agustín Ciapponi, Juan M. Sambade, Noelia Castellana, Jamile Ballivian, Martín Brizuela, Julieta Caravario, Daniel Comande, Esteban Couto, Agustina Mazzoni, Vanesa Ortega, Edward P. K. Parker, Florencia Salva, Katharina Stegelmann, John S. Schieffelin, Xu Xiong, Andy Stergachis, Flor M. Munoz, Pierre Buekens